Researchers recently developed a bone marrow model to study how the body generates cells. Interestingly, this model is the ...

John Szilagyi (left) is a Principal Scientist at Bristol Myers Squibb (NJ, USA), working in nonclinical development and investigative toxicology, with a focus on the development of models to study ...

The effectiveness of non-clinical drug safety predictions is enhanced by the adoption of three-dimensional (3D) cellular models. 3D bioprinting enables the generation of complex models with spatial ...

Most potential oncology drugs fail during the drug development pipeline, even when there has been promising data for their efficacy during the in vitro stage. This makes it vital to identify in vitro ...

We use our lips to talk, eat, drink, and breathe; they signal our emotions, health, and aesthetic beauty. It takes a complex structure to perform so many roles, so lip problems can be hard to repair ...

Biomedical research is shifting from traditional 2D monolayer cell cultures to advanced 3D cell culture technologies, which more accurately replicate biological systems. This article explores the ...

Research and drug discovery are undergoing a transformation, driven by the rise of 3D cell culture models that better replicate human biology. Unlike traditional 2D cultures and animal models, which ...

In the new study, the team used the model to demonstrate that as Alzheimer's pathology accumulates in the brain, specific types of immune cells called CT8+ T Cells surge into the brain and amplify the ...

Cancer research has long relied on traditional models such as two-dimensional (2D) cell cultures and animal models. However, ...

Global 3D cell culture market valued at $1.18B in 2024, $1.29B in 2025, and set to hit $2.26B by 2030, growing at 11.7% CAGR. 3D cell culture technologies represent a paradigm shift in biomedical ...